SUGP CALL OPTIONS
It was late last night
and I was hastful in my typing.
Maka, you are
correct. Would only lose the Call option money
However, I would like to think my pointing out the 965
moved the stock up today.
I bought 30 calls
friday after seeing the 965.
Received a 38% return
in two days.
I think SUPG will go to 35 in the
Just to clarify re: rubitican trials.
The actual protocol enrollment etc. began in January
and they will continue to enroll until the end of
December - that was what I meant by the end of the
2) My source for the current # of patients (400) is
Robert Cohen of investor relations.
initial data will begin to be analyzed at the beginning
of the year --- naturally the final full-up data
(and hence official paper, etc.) can't be done until
the last patient (enrolled say Dec 31) has had some
reaction to the protocol. However, if the results are
really strong - as in replication of phase II data
(recall I think that the range is somewhere between
parity and phase II), then the company/FDA will take
immediate notice & action --- if you had (G-d forbid)
pancreatic cancer wouldn't you demand it?
Routine med mal defense does, as you say,
regularly involve a law firm contracted to an insurer to
provide defense of claims against each of the insurer's
clients -- the sued doctors. And yes, these lawyers tend
to return to the same pool of physicians for
examination and opinion. At that point, I must stop agreeing.
Defense lawyers I know use clinicians, not exam-mills.
The reason is basic - credibility. These doctors know
the problems and can testify knowledgably, not
anectdotally (witness the disagreement between two of our
board posters re: whipple for an example). I have sent
a number of plaintiffs in non-med mal cases for
exams under the IME statutes of various states and
federal law, and have not (nor have my colleagues) chosen
a doctor based on a predisposed opinion or script.
We look at the local pool of physicians, searching
for respected, well-educated and well practiced
doctors. Period. And yes, we pay what they charge. My
experience has been that plaintiffs tend to use the same
experts repeatedly, and I have seen quacks make a killing
as a mouthpiece for hire on that side. But I do not
represent plaintiffs, and therefore am not qualified to
generalize about the state of that medical/legal connection.
I would not be surprised to find that the
plaintiffs' bar is exactly like the defense -- get the best
Re: insurers, I am not knowledgable
on their inner workings. Again, I won't generalize
or speculate. Any insurance execs or in-house
attorneys out there that can shed (informed) light?
Thanks for your responses, guys. Very
informative. The discussion on option calls seems to be a bit
speculative. What my thinking seemed to be saying was that
"insiders" are active in the stock or at least their friends
are. Very interesting thought.